MedPath

Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment

Not Applicable
Conditions
solitary primary hepatocellular carcinoma
Registration Number
JPRN-UMIN000036743
Lead Sponsor
agoya City West Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

1)pregnancy or lactation 2)severe psychological disorders 3)active and uncontrolled infection 4)Other cancers within 5 years 5)continuous systemic administration (oral or intravenous) of steroids 6)esophageal varix at high risk of bleeding (F3, Rc ++ or higher) 7)portal vein tumor thrombosis 8)cases in which the doctor is judged inappropriate for medical, psychological or other reasons other than the above

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
2-year overall survival
Secondary Outcome Measures
NameTimeMethod
local control rate, progression free survival,response rate,incidence of grade 3 or higher adverse events,change of quality of life (QOL)
© Copyright 2025. All Rights Reserved by MedPath